Who
Peter M. Kash
Director
Company insider
Files Form 4 as: Director, Xtend AI Robotics; Director, Capricor Therapeutics; Director, Velcera; Director, Javelin Pharmaceuticals.
In numbers
- Trades disclosed
- 26
- Buys
- 5
- Sells
- 0
- Bought
- $24K
- Sold
- $0
- Companies
- 4
- Companies where not an officer
- 4
- First trade
- 8 Mar 2006
- Last trade
- 15 Oct 2026
- Last filed
- 19 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 15 Oct 2026filed 19 Oct 2026 | XTND Xtend AI RoboticsAerospace & Defense | SEC FORM 4 Code A | —141,509 at $0.00 | filing |
| 18 Jul 2011filed 19 Jul 2011 | CAPR Capricor Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code J | —19,500 at $0.00 | filing |
| 10 May 2011filed 12 May 2011 | CAPR Capricor Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —80,000 at $0.00 | filing |
| 26 Jul 2010filed 28 Jul 2010 | CAPR Capricor Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —80,000 at $0.00 | filing |
| 21 Jul 2009filed 23 Jul 2009 | CAPR Capricor Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —80,000 at $0.00 | filing |
| 15 Jul 2009filed 16 Jul 2009 | CAPR Capricor Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code J | —125,000 | filing |
| 7 Jul 2009filed 9 Jul 2009 | CAPR Capricor Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code P | —24,704 | filing |
| 7 Jul 2009filed 9 Jul 2009 | CAPR Capricor Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code P | —24,703 | filing |
| 7 Jul 2009filed 9 Jul 2009 | CAPR Capricor Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code P | —49,407 | filing |
| 7 Jul 2009filed 9 Jul 2009 | CAPR Capricor TherapeuticsBiotechnology | SEC FORM 4 Bought | —98,814 | filing |
| 23 Dec 2008filed 23 Dec 2008 | CAPR Capricor Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —35,000 at $0.00 | filing |
| 12 Dec 2008filed 12 Dec 2008 | CAPR Capricor TherapeuticsBiotechnology | SEC FORM 4 Bought | $1,5751,500 at $1.05 | filing |
| 12 Dec 2008filed 12 Dec 2008 | CAPR Capricor TherapeuticsBiotechnology | SEC FORM 4 Bought | $3,5002,500 at $1.40 | filing |
| 11 Dec 2008filed 12 Dec 2008 | CAPR Capricor TherapeuticsBiotechnology | SEC FORM 4 Bought | $408600 at $0.68 | filing |
| 25 Jan 2008filed 29 Jan 2008 | CAPR Capricor Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —60,000 at $0.00 | filing |
| 24 May 2007filed 29 May 2007 | Velceraoption or derivative | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 8 Dec 2006filed 12 Dec 2006 | Javelin Pharmaceuticalsoption or derivative | SEC FORM 4 Code J | $337K87,116 at $3.87 | filing |
| 8 Dec 2006filed 12 Dec 2006 | Javelin Pharmaceuticalsoption or derivative | SEC FORM 4 Code J | $277K51,742 at $5.36 | filing |
| 8 Dec 2006filed 12 Dec 2006 | Javelin Pharmaceuticalsoption or derivative | SEC FORM 4 Code J | $60K30,552 at $1.96 | filing |
| 8 Dec 2006filed 12 Dec 2006 | Javelin Pharmaceuticalsoption or derivative | SEC FORM 4 Code J | $95K35,000 at $2.70 | filing |
News
No headline names them, or the companies they trade most, lately.